Home>Topics>>Incyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Incyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Healthcare Sector and Stocks Analysis from Seeking Alpha
Thu, 14 Feb 2013
Incyte Corporation ( INCY ) Q4 2012 Earnings Call February 14, 2013 8:30 am ET Executives Pamela Murphy - VP, IR & Corporate Communications Paul Friedman - President & CEO Jim Daly - EVP & CCO Dave Hastings - EVP & CFO Rich Levy - EVP, Chief Drug Development & Medical Officer Analysts Matt Roden - ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.